Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects
Clinical trial NCT03235076 · COMPLETED
Trial details
- NCT number
- NCT03235076
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2018-11-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.